IPOPLUS

545.2

+13 +2.44%

18 Jun 2026

NSE Listed · Pharmaceuticals

Panacea Biotec Ltd. (PANACEABIO)

Volume: 23,296Avg Vol 1W: 71,050Avg Vol 1M: 83,73752W Range:292.4647
₹545.2 2.44%
Market Cap₹3,291 Cr
Current Price₹545.2
Previous Close₹532.2
High / Low (52w)₹647 / ₹292.4
Volume23,296
Avg Vol (1W)71,050
Avg Vol (1M)83,737
Stock P/E
Book Value₹136.19
Dividend Yield0%
ROE-2.93%
ROA-0.57%
Revenue (TTM)
Revenue Growth-0.01%
Profit Margin-0.84%
Total Debt₹15 Cr
Shares Outstanding6 Cr
Face Value₹1
EPS (TTM)₹0.08
P/B3.97
Debt / Equity0.03
50 DMA₹417.49
200 DMA₹368.4
Day change+2.44%
Price Chart
545.2 35.57% · 1Y
6082962.4Cr
2025-10-01
2026-06-16

20-day avg volume: 91K shares

Pros
  • Company is almost debt-free.
Cons
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹167 Cr₹165 Cr₹141 Cr₹167 Cr₹133 Cr₹163 Cr₹147 Cr₹116 Cr₹136 Cr₹151 Cr₹143 Cr₹129 Cr₹129 Cr₹115 Cr₹105 Cr₹111 Cr₹141 Cr₹156 Cr₹232 Cr₹132 Cr₹168 Cr₹142 Cr₹182 Cr₹133 Cr₹125 Cr
EBITDA₹-3 Cr₹6 Cr₹-20 Cr₹-4 Cr₹-27 Cr₹3 Cr₹3 Cr₹-19 Cr₹-4 Cr₹-4 Cr₹-10 Cr₹-14 Cr₹0 Cr₹-4 Cr₹-3 Cr₹-78 Cr₹-37 Cr₹3 Cr₹-3 Cr₹-9 Cr₹-6 Cr₹6 Cr₹29 Cr₹12 Cr₹-15 Cr
Net Profit₹1 Cr₹4 Cr₹-14 Cr₹4 Cr₹-2 Cr₹5 Cr₹5 Cr₹-16 Cr₹-2 Cr₹-2 Cr₹-8 Cr₹11 Cr₹-13 Cr₹19 Cr₹16 Cr₹-56 Cr₹1,237 Cr₹-49 Cr₹-53 Cr₹-57 Cr₹-54 Cr₹-40 Cr₹-19 Cr₹-34 Cr₹-70 Cr
EPS0.080.65-2.20.66-0.310.740.77-2.59-0.23-0.37-1.351.79-2.033.162.56-9.17202.03-8.03-8.65-9.36-8.84-6.54-3.16-5.58-11.38
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹580 Cr₹585 Cr₹512 Cr₹672 Cr₹635 Cr₹574 Cr
EBITDA₹-40 Cr₹-31 Cr₹-85 Cr₹-46 Cr₹41 Cr₹18 Cr
Net Profit₹-8 Cr₹-1 Cr₹-33 Cr₹1,078 Cr₹-148 Cr₹-194 Cr
EPS-1.37-0.19-5.43176.05-24.11-31.72
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹1,290 Cr₹1,241 Cr₹1,271 Cr₹1,759 Cr₹1,178 Cr₹1,390 Cr
Total Liabilities₹459 Cr₹402 Cr₹431 Cr₹885 Cr₹1,409 Cr₹1,195 Cr
Equity₹831 Cr₹838 Cr₹840 Cr₹874 Cr₹-232 Cr₹196 Cr
Total Debt₹15 Cr₹15 Cr₹15 Cr₹30 Cr₹732 Cr₹610 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹-26 Cr₹2 Cr₹-420 Cr₹295 Cr₹108 Cr₹-22 Cr
Investing₹65 Cr₹10 Cr₹430 Cr₹1,283 Cr₹-48 Cr₹-35 Cr
Financing₹-3 Cr₹-3 Cr₹-18 Cr₹-1,176 Cr₹-47 Cr₹91 Cr
Free Cash Flow₹-26 Cr₹2 Cr₹-420 Cr₹295 Cr₹108 Cr₹-22 Cr
Shareholding
Promoter 72.48% Institutions 3.56% Public 23.96%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search